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Abstract 
 
Cation diffusion facilitator (CDF) proteins are a conserved family of transmembrane transporters that 
ensure cellular homeostasis of divalent transition metal cations. Metal cations bind to CDF protein’s 
cytoplasmic C-terminal domain (CTD), leading to closure from its apo open V-shaped dimer to a 
tighter packed structure, followed by a conformational change of the transmembrane domain thus 
enabling transport of the metal cation. By implementing a comprehensive range of biochemical and 
biophysical methods, we studied the molecular mechanism of metal binding to the magnetotactic 
bacterial CDF protein MamM CTD. Our results reveal that the CTD is rather dynamic in its apo form, 
and that two dependent metal binding sites, a single central binding site and two symmetrical, 
peripheral sites, are available for metal binding. However, only cation binding to the peripheral sites 
leads to conformational changes that lock the protein in a compact state. Thus, this work reveals how 
metal binding is regulating the sequential uptakes of metal cations by MamM, and extends our 
understanding of the complex regulation mechanism of CDF proteins. 
 
Introduction 
 
Protein-metal cation interactions are key players in the function of many biological process, whether 
they serve as structural anchors (as in zinc fingers [1]), participate directly in enzymatic reactions (as 
in the calcium/manganese cluster in photosystem II [2] or copper in tyrosinases’ active site [3]) or 
stabilize enzymes’ active sites (as in magnesium in metallonucleases’ active sites [4]). Since metal 
cations are rather small ligands they can easily diffuse into empty but charged binding sites, thus 
metal-ligand binding processes usually occur quite quickly [5]. These cations must bind selectively in 
their specific binding sites to ensure the correct conformational changes and function [6]. 
Understanding the exact mechanism of this type of binding, especially in terms of how these 
interactions occur and lead to conformational changes on short time scales, is of huge value for the 
study of the overall mechanism of a specific protein. However, the molecular mechanism of protein-
metal binding is often not well characterized, and such knowledge is lacking in many protein families.  
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
The cation diffusion facilitator (CDF) family is an example of a protein class where such protein 
metal binding is not well understood. CDFs are a divalent transition metal cation transporter family 
that maintain such cation homeostasis, and are conserved throughout all domains of life [7]. CDF 
proteins export a range of divalent metal cations, such as Zn2+, Mn2+, Fe2+, Cd2+ and Co2+ out of the 
cytoplasm,  typically by exploiting the proton motive force while undergoing conformational change 
[8–10]. CDF proteins form hetero- or homodimers and contain two major domains: the 
transmembrane domain and the cytoplasmic C-terminal domain (CTD). The transmembrane domain 
is found in all known CDF proteins and includes six helices per monomer as well as a well-
characterized metal binding site through which the metal cations are transported  [9–11]. The CTD 
domain is abundant in CDF proteins, adopting a metallochaparone-like fold and undertaking metal-
binding-related conformational changes [12,13]. The CTD has been better characterized both 
structurally and biochemically than the transmembrane domain, and it has been proposed to act as a 
regulatory domain. The CTD contains metal binding sites which are found on the protein surface, thus 
exposed to cytoplasmatic metal ions. With quite low affinity to metals, it has been speculated that in 
high cytoplasmic metal concentrations, the metal cations are bound to these CTD binding sites. This 
causes a conformational change where the two monomers, that were found in an apo V-shaped 
conformation, approach each other to form a tighter V-shaped conformation. This, in turn, induces a 
conformational change of the transmembrane domain allowing the efficient, fast transport of cations 
through this domain (which has greater affinity) [8,13]. Namely, only at high levels of metals 
(concentrations that approach cytotoxicity) will they be bound to the CTD to activate the actual 
transport. In contrast to the transmembrane binding site, the metal binding sites in the CTD are not 
fully conserved in terms of properties, location and number (although in most proteins more than one 
binding site has been proposed) [14]. The exact binding mechanism and its energetics, the kinetic 
pathway by which metal binding induces these proposed structural changes, and how the ions bind 
and interact with the CTD, remain poorly understood. A number of specific questions are yet to be 
addressed, including how the metal binding sites are populated during activation, and if there is an 
ordered binding sequence. Furthermore, whether allostery and cooperativity exist and play a 
functional role in CTD activation, and finally if all metal binding sites are required to fully induce the 
conformational change and activation of the CTD.  
To address these questions, the metal binding mechanism in MamM CTD, a CDF protein from 
magnetotactic bacteria (MTB), has been investigated. MTB are a group of Gram-negative bacteria 
that biosynthesize iron-based magnetic particles in designated organelles named magnetosomes. 
These magnetosomes are arranged in a chain-like fashion, thus enabling them to align themselves to 
the geomagnetic field in order to reach their preferred habitat, usually the oxic-anoxic zones in aquatic 
environments [15,16]. MamM transports iron from the bacterium cytoplasm into such magnetosomes, 
which enables synthesis of iron-based magnetic particles inside the vesicles. In the absence of MamM 
or in case of mutations that cause its dysfunction, these particles are either not formed or formed 
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defectively [13,17–19]. Since such differences in magnetic particle formation in MTB are easy to 
study, MamM serves as an effective model to study CDF proteins. The MamM CTD structure has 
been solved in its apo form, and a comprehensive biophysical study has revealed that it undergoes 
conformational change when it binds Fe
2+
 and Zn
2+
 in three proposed binding sites: two symmetrical 
peripheral binding sites and one central binding site. Mutations in these postulated binding site 
residues lead to a decreased function both in vivo and in vitro [13]. Here a combination of different 
biophysical methods is used to study MamM CTD dynamics and kinetics, in order to decipher the 
protein-metal binding mechanism. Overall, the unique combination of X-ray crystallography, circular 
dichroism (CD) spectroscopy, pulsed electron paramagnetic resonance (EPR and PELDOR) 
spectroscopy, molecular dynamics (MD), isothermal titration calorimetry (ITC), fluorescence 
spectrometry and stopped flow results reveal a dependence between the central and peripheral binding 
sites, and that rapid binding occurs at the central binding site while only binding to the peripheral sites 
induces significant conformational change. These results reveal the complexity of metal binding to 
MamM specifically and to CDF proteins’ cytoplasmic domain in general, and constitute a significant 
step towards the understanding of the diverse regulation mechanisms in CDF proteins and their 
contribution to CDF protein function. 
 
Results 
 
Previously it was shown that metal binding to MamM CTD in vitro occurs only at basic pH due to the 
involvement of histidine residues in the coordination of the metal ions [13]. Fe
2+
 tends to precipitate at 
basic pH, however its effective concentration is highly important for stoichiometry determination and 
interpretation of the kinetic mechanism of ligand binding. Hence, for this reason and also to enable a 
comparison with previous studies utilizing Zn
2+
 as a model for metal binding [13], we performed a 
structural, thermodynamic and kinetic investigation of Zn
2+
 to study the metal binding mechanism in 
MamM CTD. 
 
Structural studies of MamM CTDs indicate binding-dependent conformational change 
MamM CTD is arranged as a stable dimer forming two putative symmetrical peripheral sites 
(histidine 264 and glutamate 289 of monomer one and two, respectively) and one central binding site 
formed with a quartet of residues (aspartate 249 and histidine 285 from each monomer) (Figure 1A)  
[13]. To understand the MamM CTD-Zn
2+
 binding mechanism, constructs termed WT (wildtype 
MamM C-terminal domain residues 215-318), PS (peripheral site; WT with D249A and H285A 
mutations which abolishes the central binding site, construct contains only the peripheral sites) and 
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CS (central site; WT with H264A and E289A mutations which abolishes the peripheral binding sites, 
construct contains only the central site) were used.  
The crystal structure of the apo WT protein, which has been solved previously, displays the 
characteristic fold of CDF proteins (PDB ID: 3W5X, 3W5Y) [13]. The crystal structures of both the 
apo PS construct (PDB ID: 3W8P, 3W66) [13] as well as the apo CS construct (PDB ID: 6G64, 
Tables 1-3, Figure 1B) which was solved for this study reveal no differences as compared to the WT 
structure (see Table 4 for RMSD data between the different structures), suggesting that the apo forms 
do not differ in their three dimensional crystal structures. Since, it has not yet proven possible to 
crystallize the different MamM CTD constructs in the presence of Zn2+, other structural methods have 
been applied to better understand the conformational changes occurring due to metal binding. 
Circular dichroism (CD) spectra of all apo protein constructs (WT, PS and CS) confirmed that the 
secondary structures of all three proteins are also conserved in solution (Figure 2). The CD spectral 
trends after addition of Zn
2+
 (protein:Zn
2+
 at 1:15 ratio) are consistent with the apo forms, suggesting 
that the conformational changes occurring due to metal binding do not involve substantial changes in 
their secondary structures, but most likely at the dimerization interface, similar to the CDF protein 
CzrB [12].  
To further understand the MamM CTD metal-dependent conformational changes, site-directed spin 
labelling was applied in combination with pulsed electron-electron double resonance (PELDOR) 
spectroscopy [20,21], which affords the detection of both distances and distance distributions between 
labelled sites within the dimer. During site-directed spin labelling, the paramagnetic (1-oxyl-2,2,5,5-
tetramethylpyrrolidin-3-yl)methylthiosulfonate spin label (MTSSL) reacts specifically with cysteine 
residues of the protein. MamM CTD contains two intrinsic cysteine residues, C267 and C275, the 
second of which is found on the periphery of the protein in a solvent-exposed region. Both in silico 
modelling and spin labelling efficiencies indicate that C267 does not label well, hence PELDOR 
experiments were performed using the C267S variant protein which provides only distances between 
the two labelled C275 sites on the protein (Figure 1C). In silico prediction of inter-spin label distances 
was carried out using Multiscale Modelling of Macromolecules (MMM) [22], a Matlab
©
-based open-
source modelling toolbox. 
This C267S mutation was introduced by site-directed mutagenesis to all three MamM CTD 
constructs: C267S (WT with C267S mutation), PS-C267S (PS with C267S mutation) and CS-C267S 
(CS with C267S mutation). Crystallization trials were performed on these constructs to confirm that 
the C267S mutation also does not alter the protein structure. Only the C267S and CS-C267S 
constructs formed crystals allowing a structure to be determined (PDB IDs: 6G55 and 6G5E, 
respectively, see Tables 1-3 and Figure 1B). In both cases the structure revealed no difference to the 
wild type structure. All variant proteins labelled efficiently, indicating good accessibility of the C275 
site. Further, by using the structure of the apo C267S form, the MMM study predicted an inter spin 
distance of 4.0 nm between the labelled cysteines at this position (C275, Figure 1C). 
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In Figure 3 PELDOR experiments of all three apo forms (as well as Zn
2+
-bound) are presented. The 
upper panels of Figure 3 present the background-subtracted time-domain traces for both apo and 
metal-bound protein, while the lower panels represent the distance distribution probability of the 
metal bound-state after data analysis using DeerAnalysis 2016 [23]. Both the apo forms of C267S and 
CS-C267S revealed no defined distance between the two labelled cysteines, suggesting that these 
proteins do not adopt a single stable conformation in this state, but are rather dynamic (Figure 3A-B). 
In the PS-C267S apo protein, however, a strong initial decay of the PELDOR signal in the time 
domain was observed which is quite different from the C267S and CS-C267S time domain spectra 
(Figure 3C). Such initial steep decays can be indicative of very short distances, typically < 2 nm 
between the labels. In the apo WT protein, the negatively charged aspartate and bulky histidine 
residues that form the putative central site protrude towards one another in the space between 
monomers, resulting in clashes and/or charge repulsion. This could increase the distance between 
monomers. Removal of these residues from the dimer interface could in principle allow for more 
stable and tighter packing as compared to the apo WT protein, however the direct closure of the V-
shape dimer would not be in agreement with a short inter spin distance inferred from the PELDOR 
time-domain results. It was previously suggested that the two monomers could also swivel along a 
perpendicular axis [13] rather than simply moving laterally towards one another. Hence removal of 
these charged, bulky residues in PS-C267S could allow for a larger degree of swiveling movement 
and thus explain the proposed short inter spin distance in PS-C267S.  
Addition of zinc chloride (x 5 excess) to each MamM CTD form (C267S-Zn
2+
, PS-C267S-Zn
2+
 and 
CS-C267S-Zn
2+
) results in large changes in the PELDOR time-domain traces (Figure 3 upper panels). 
For C267S-Zn
2+
 a narrow distance distribution was determined with a mean distance of 3.3 nm 
(Figure 3A, lower panel), indicative of a predominantly closed conformation upon metal binding 
which is rigid compared to the apo form and slightly shorter than the MMM prediction. A systematic 
Zn
2+
 titration (from 1:1 to 1:10 protein:metal ratios) revealed that the observed modulation depth 
increases with the successive addition of Zn
2+
 up until a ratio of 1:3-1:4 where it reaches a saturation 
point, which can be indicative of 3-4 Zn
2+
 ions bound per dimer (Figure 4 left panels and Table 5). 
Beyond this ratio no further increase in modulation depth is observed and indeed there is only a slight 
decrease which is due to the high metal ion and protein concentrations, which is known to cause 
aggregation in solution. An increase in modulation depth was also observed for CS-C267S-Zn
2+
 
compared to its apo state, however the distance distribution obtained was extremely broad, indicating 
that a single stable conformation was not adopted in the presence of the Zn
2+
 (Figure 3B). This 
suggests that whilst the addition of metal has some effect on the structure and dynamics of the protein, 
an entirely closed and rigid Zn
2+
-bound state is unlikely to be present. Hence, mutation of the 
peripheral binding sites does affect metal binding and does not allow meaningful conformational 
changes to be observed. For PS-C267S-Zn
2+
, again a predominant, but distinct narrow distance 
distribution is obtained, with a mean distance of 2.7 nm (Figure 3C). This result would suggest that 
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the addition of Zn
2+
 causes PS-C267S to adopt a slightly different rigid conformation, where the spin 
labels are now further apart as compared to the apo state. Such a 2.7 nm distance would fit with a tight 
V-shape packing that is not possible in the WT protein due to the presence of the histidine and 
aspartate residues in the metal binding site, which are proposed to increase the gap between the 
monomers as compared to this alanine mutant. Repeating the Zn
2+
 titration experiment with PS-
C267S MamM CTD with Zn
2+
 (from 1:1 to 1:5 protein:metal ratios) reveals an increase in modulation 
depth with successive addition of Zn
2+
 up until a ratio of 1:2, at which point saturation is already 
reached and no further increase is observed (Figure 4 right panels and Table 5). This clearly indicates 
that less Zn
2+
 ions are bound per dimer of PS and indeed fits well with the proposal that only two Zn
2+
 
ions are bound, one in each peripheral site. In summary, it is proposed that Zn
2+
 addition to PS results 
in its binding to the peripheral sites only, which restricts the swiveling movement and stabilizes the 
protein in a “native-like” closed conformation, but with tighter packing due to removal of the bulky 
residues at the central site.  
Overall, the PELDOR results obtained, both when comparing apo and Zn
2+
-bound states of each 
variant forms as well as between the Zn
2+
-bound forms of the different MamM CTDs, suggest that the 
protein adopts a closer packing in solution upon addition of metal ions, and that the residues in both 
peripheral and central sites have an influence on, and are important for metal binding and 
conformational change.  
 
Apo-MamM CTDs demonstrate different dimerization dynamics 
In order to study the effect of mutations on apo-MamM dynamics, and to assess whether the proposed 
swiveling movement is possible, molecular dynamics (MD) simulations were also used. As CS was 
shown to behave similarly to WT in their apo forms, MD was only applied to WT and PS. Later, the 
MD trajectories were studied using principal component analysis (PCA). PCA, also known as 
essential dynamics, is an analysis method that reduce the dimensionality of a complex system while 
retaining the most important features of the distribution of conformations [24–26]. 
Initially, the stability of each simulated protein was validated, and the root mean square deviation 
(RMSD) values of the backbone were calculated. As MamM CTD is a homodimer, the RMSDs for 
each monomer and of the dimer were calculated separately. Calculated values of backbone RMSD for 
the production stage (after the initial 20 nsec) of each simulation are 0.13 ± 0.02 nm (monomer 1, 
WT), 0.11 ± 0.01 nm (monomer 2, WT), 0.31 ± 0.10 nm (dimer, WT), 0.11 ± 0.01 nm (monomer 1, 
PS), 0.13 ± 0.02 nm (monomer 2, PS) and 0.31 ± 0.13 nm (dimer, PS). The outcome indicates that 
following an initial reengagement, the 3D structure of all monomers is highly stable. On the other 
hand, while both WT and PS maintain their dimers, their averaged RMSDs are higher. In addition, 
their RMSDs show a higher rate of fluctuation (data not shown). This RMSD profile is likely to be 
due to the movement of one monomer towards the other.  
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To further study the dynamics of MamM dimers, the first two modes of motions (modes 7 and 8) 
calculated using PCA were used. Modes 7 and 8 are the largest collective motions of groups of atoms 
following the removal of translation (modes 1 to 3) and rotation (mode 4 to 6) movements of the WT 
and PS complexes. The translation and rotations are removed as they are not contributing to the 
molecule flexibility. First, the calculated fluctuations of modes 7 and 8 were compared with the those 
calculated from the MD trajectories. The fluctuation profiles were found to be very similar (Pearson 
correlation coefficient are R=0.97 and 0.96 for WT and PS, respectively), indicating that modes 7 (the 
native-like open-close movement) and 8 (the swiveling movement) account for most of the overall 
protein motion. Furthermore, this confirms that low-frequency motions govern MamM-complex’s 
overall dynamics. A comparison of WT and PS revealed that PS is more flexible than WT (Figure 5). 
Whereas most fluctuations in the WT are located at the top of the beta-sheet, in PS a larger portion of 
the protein fluctuates. Moreover, the magnitude of fluctuations in PS is larger compared to the WT’s. 
In addition, fluctuations at mode 8 of PS reveals a large amplitude of swiveling movements, unlike 
WT (Figure 5, bottom panel). Taken together, the simulations suggest that the lack of the binding 
residues in the central site effects the apo-MamM dynamics as was also proposed by the EPR results, 
with the apo-PS undergoing a more pronounced dynamic swiveling movement.  
 
Stoichiometry of Zn
2+
 binding to MamM CTD constructs  
The occupancy of the three MamM CTD binding sites during its activation in solution have not been 
determined previously. PELDOR results would suggest that 3 or 4 ions are bound to the WT construct 
while only 2 ions bind to the PS construct. In order to formulate a kinetic model for metal binding 
during activation of MamM CTD, the binding stoichiometry of divalent ions must be precisely 
determined for all protein constructs. For that, Zn
2+
 and the three MamM CTD constructs WT, PS and 
CS were utilized. Equilibrium ligand binding was performed by isothermal titration calorimetry (ITC) 
to determine MamM CTD-Zn
2+
 binding thermodynamic parameters and stoichiometry, i.e., how many 
metal ions are bound per MamM CTD homodimer. In Table 5 the summary of the ITC experiments 
with WT and the PS mutant is presented. The CS revealed no heat change on Zn
2+
 concentration-
dependent binding (Figure 6). The PELDOR experiments and fluorescence measurements (see below) 
did however indicate Zn
2+
 concentration-dependent binding. It can be speculated that Zn
2+
 binding to 
CS does not generate a large enough heat capacity change in the system to be detected. When 
considering that Zn
2+
 binding to the central binding site leads to minor conformational changes, as is 
evident from results obtained by the other methods employed, it is more probable that the entropy and 
enthalpy changes are balanced such that overall nearly no change in the Gibbs free energy of the 
system is observed. Both WT and PS show similar parameters (Table 5), but PS shows a slightly 
preferred binding to Zn
2+
 in terms of thermodynamics parameters (~ 57% lower   , as well as slightly 
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lower   , which is characterized by both smaller    and larger   ). However, WT shows a greater 
  value (2.80  0.24) as compared to PS (2.41  0.24). This would mean that while WT can bind ~ 3 
Zn
2+
 ions per dimer, in clear agreement with the PELDOR titration data, PS can only bind ~ 2-2.5 ions 
but with slightly higher affinity, again corroborated by the PELDOR data. These ITC results suggest 
that each peripheral site can bind one ion, and the central site is occupied by a single ion that has 
almost no impact on the heat of the system. In the case of the PS construct, the mutated central site 
that lacks the histidine and aspartate residues cannot bind the Zn
2+
 ion effectively, but the binding to 
this PS construct is thermodynamically preferred, most likely due to a more stable conformational 
change caused by Zn
2+
 binding to the peripheral sites, as compared to the WT protein.  
 
Interpretation of the fluorescence signal arising from metal binding to MamM CTD  
Upon analysis of the MamM CTD sequence one tryptophan (W247) residue per monomer was 
identified, juxtaposed to the central binding site (Figure 1A), and one tyrosine residue, Y241, that is 
remote from both the central and peripheral binding sites, but which may still contribute to any 
intrinsic fluorescence change upon binding of metals after excitation at ex 280 nm. Indeed, metal 
binding to MamM CTD has been shown to induce a change in the intrinsic fluorescence signal upon 
excitation at ex 280 nm [13]. To detect whether similar differences in the fluorescence signal occur 
due to Zn
2+
 binding in the different MamM CTD constructs, fluorescence measurements were 
conducted upon Zn
2+
 binding to MamM CTD as a function of Zn
2+
 concentration (Zn
2+
:MamM CTD 
ratios were varied from 0:1 to 100:0) (Figure 7A-C). In order to be assured that the fluorescence 
signal observed is only contributed by the W247 residue and not by the Y241 residue, a more specific 
excitation wavelength of ex 297 nm was used which is towards the tryptophan. Indeed, a point 
mutation to remove this particular tryptophan residue, W247A (WT with W247A mutation), abolishes 
completely the fluorescence signal (Figure 7D). The crystal structure of this mutant (Figure 1D), 
which also confirms the substitution, reveals the same monomeric fold as that of the WT, and a very 
similar dimerization interface with only a minor shift of the monomers towards one another, probably 
due to the crystal packing. The tryptophan fluorescence emission spectra of the MamM CTD proteins 
reveal a Zn
2+
 concentration-dependent blue shift of the spectrum for all the different MamM CTD 
constructs, as well as an increase in fluorescence intensity. These results suggest a shift of W247 
towards a more hydrophobic environment in the presence of Zn
2+
, hinting at a Zn
2+
-dependent 
conformational change. When comparing the MamM CTD WT data with those of PS (Figure 7A, B, 
E, F), WT demonstrates a greater blue shift and an increase in fluorescence intensity in the presence 
of Zn
2+
. This is most likely due to: (1) The alanine substitution at position 249 in PS which is 
juxtaposed to the W247 residue, which will influence the initial tryptophan environment 
hydrophobicity and leads to a lower initial max, and (2) a closer, or different, apo V-shaped conformer 
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in solution, which is possible due to the lack of D249-D249 repulsion and the removal of the bulky 
H285 residues from the center of the V-shape dimer, as is also proposed from both the PELDOR and 
MD data. In contrast, upon addition of Zn
2+
 to the CS construct, there is a large increase in intensity as 
compared to the other MamM CTD constructs while only a minor blue shift is observed. This would 
suggest that the CS construct is somehow affected differently by the presence of Zn
2+
 which is 
reinforced by the lack of clear detectable binding as determined by both the ITC and PELDOR 
spectroscopy. The Zn
2+
 concentration-dependent maximum wavelength plots were fitted to a 
hyperbolic equation with    values determined using the point of half saturation for protein-Zn
2+
 
binding (WT and PS are 18.66 ± 3.54 µM and 82.72 ± 9.23 µM, respectively). These values differ 
from values calculated from the ITC, but with similar order of magnitude. These differences are most 
likely due to the fluorescence curves reflecting only binding that is affected by the fluorescence signal 
and therefore should only provide a first estimate of metal affinities to MamM CTD. Importantly, the 
ITC values should be considered as the hard parameters for the model. Nonetheless, both methods 
give    values of the same order of magnitude although the concentrations used in the fluorescence 
measurements were 10 times lower than that used in the ITC, suggesting that indeed the affinity is in 
the micromolar range, as can be expected from protein-surface bound metals in general, and from the 
CDFs’ CTD in particular [13,27].  
 
Kinetics of Zn
2+
 binding to MamM CTD constructs  
The kinetics of Zn
2+
 binding to MamM CTD has been measured to investigate the dynamics of metal 
binding and to identify any biochemical intermediates during the time course of its binding reaction. 
Upon Zn
2+
 binding, an increase in the intrinsic tryptophan fluorescence of both WT and PS can be 
nicely observed (Figure 8A, B). However, for CS no time-dependent changes in tryptophan 
fluorescence are detected (Figure 8C). Nevertheless, careful inspection of CS time traces suggests that 
a rapid binding event, within the dead time of the stopped flow experiment (1.5 msec), might be 
occurring, due to the higher fluorescence already observed at time zero as a function of the increasing 
Zn
2+
 concentration. In addition, the fluorescence changes upon Zn
2+
 binding to the CS construct are 
nicely shown in Figure 7C, E, F.  
The time courses of the fluorescence increase upon rapid mixing of Zn
2+
 with WT, follows a single 
exponential up to 500 msec. Beyond this time regime the fluorescence intensity decreases, most likely 
due to relatively high photobleaching of the W247 residue in each monomer. The ITC stoichiometric 
model fitting predicts three Zn
2+ 
ions binding per WT dimer (Table 5). Structurally, this can account 
for the two identical peripheral sites and the one central site which is formed at the interface of the 
two monomers. Multiple binding sites which are not identical in terms of their chemical composition 
are less likely to yield an identical spectroscopic signature. Therefore, it was not expected that rapid 
binding kinetics exhibits only a single kinetic phase as shown by the mono-exponential fluorescence 
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intensity. The observed single phase may be due to binding occurring during the stopped flow dead 
time (~1.5 msec) to either sites, to a fluorescence silent binding site or to a combination of both. 
Based on the WT and the mutants’ PELDOR, fluorescence and ITC data, we favour that the measured 
fluorescence increase in the transient time course reflects the binding of Zn
2+ 
to the peripheral sites 
according to the general Scheme 1. The initial binding of Zn
2+
 to the central site is rapid, occurring 
within the dead time of the stopped flow with a binding rate > 1,000 sec
-1
 (shown in squared 
parenthesis:      and      are open and the slightly more closed conformers of CTD, respectively; 
complexes without a dot represent a strongly bound state). This is followed by a rapid collision 
complex formation of two Zn
2+
 ions binding to the peripheral sites followed by an additional 
isomerization reflected by formation of a high fluorescence state termed ‘compact closed’ (CTDCC, 
Figure 9). The microscopic rate constants are global binding parameters that reflect binding to both 
peripheral sites since we cannot distinguish between the two (Scheme 1). The observed rate constant 
(    ) of Zn
2+
 binding
 
to
 
WT exhibits a hyperbolic-dependence on Zn
2+
 concentration (Figure 8D). 
Based on the kinetic Scheme 1, and under the assumption that         
              
        
          , the observed rate constant for Zn
2+
 binding is predicted to follow a rectangular hyperbola 
and can be fitted accordingly to Equation 1:  
k
obs
=
K
PS
×k
+ps
CC[Zn2+ ]
1+ K
PS
[Zn2+ ]
æ
è
ç
ö
ø
÷ + k-ps
CC
         (Equation 1) 
Where     represents the equilibrium constant for Zn
2+
 binding to the peripheral sites and     
   
reflects the isomerization rate constant suggesting further closure of the CTD central cleft. The best fit 
of Zn
2+
 concentration-dependence binding to the WT according to Eq. 1 yields an equilibrium 
constant     
  = 62.6 ± 13.0 µM and an isomerization rate constant of     
  ≈ of 39.2 ± 1.4 sec-1 (see 
all rate constants in Table 6). The intercept of the fit is indistinguishable from the origin; thus, Zn
2+
 
binding is essentially irreversible (    
   >>    
   ~0), consistent with the results of slow Zn
2+
 
dissociation kinetics (see below, Figure 8F). The apparent second order binding constant      
  
    
    = 0.63 ± 0.14 μM
-1
 sec
-1
, is surprisingly slow in comparison to a small ligand such as a charged 
ion binding to a protein [5], suggesting that the reaction is not diffusion limited. Interestingly, 
dissociation kinetics of Zn
2+ 
measured by mixing a pre-equilibrated WTZn2+ with excess of EDTA 
exhibited double exponentials (Figure 8F). The dissociation rate constants,            = 2.4  0.1 sec
-1
 
and            = 0.20  0.07 sec
-1
 may reflect dissociation events from the two different Zn
2+
 binding 
sites, the peripheral sites and the central site. However, the fact that similar dissociation kinetics are 
seen with PS (Figure 8G) and with similar magnitudes to the WT,            = 4.6  0.1 sec
-1
 and 
           = 0.46  0.02 s
-1
, that was determined to not bind Zn
2+
 in the central site by the PELDOR 
and ITC measurements, would suggest otherwise. Furthermore, the faster dissociation rates suggest 
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that PS binds Zn
2+
 with a different conformation at the peripheral sites. The intercept in Figure 8D is 
similar to the slower dissociation rate measured directly (    
   ~ 0 &            = 0.20  0.07 sec
-1
, see 
Table 6) favoring a slower isomerization occurring before complete dissociation. Both WT and PS 
dissociation kinetics demonstrate that structurally the peripheral sites exchange Zn
2+
 with EDTA 
which can compete over the coordination of Zn
2+
 at these sites. Along with these arguments, we favor 
a two-step dissociation kinetic from the peripheral sites.  
The amplitudes of the peripheral sites’ binding kinetics are related to the fractional bound Zn2+, and 
therefore to their overall affinity. Since these amplitudes report binding of two ligands to two identical 
sites, we utilized a simple Hill model. The fitting of the amplitudes for the WT according to Equation 
2 is shown in Figure 8E with a      = 33.9   1.3 M and a moderate Hill coefficient     = 1.61  
0.13 (Table 6).  
            (Equation 2) 
Comparison of the equilibrium constant measured by ITC for WT (   = 31.5  3.4 M, Table 5) with 
the equilibrium constant determined by the Hill model suggests that the overall affinities of both the 
central site and peripheral sites in the WT protein are only marginally different, though their kinetics 
seems to be on a very different time scale. This further agrees with the rapid dissociation from the 
central site as the ‘on rate’ is also very fast. This is not to classify them as similar in terms of their 
binding kinetic pathways and the impact of their binding on the allostery they may induce on each 
other. 
Although PS displays a similar single-phase behavior (Figure 8B), with fluorescence increase upon 
Zn
2+
 binding, the      dependence on Zn
2+
 concentration decreases rather than increases (Figure 8D, 
Table 6). Therefore, it may be that PS exhibits a different mechanism for Zn
2+
 peripheral site-binding 
than WT. In PS the fast binding step to the central site does not occur in the dead time as it does for 
WT. This is also evidenced by the PELDOR and ITC results which reveal a lower stoichiometry of 
Zn
2+
 binding to PS (Table 5,   = 2 and  = 2.41  0.24 respectively), most likely only to the 
peripheral sites. This behavior is well-matched with a slower step of ‘close’ to ‘open’ conformational 
change preceding the metal ligand binding step to a ‘selected conformation’ (open state) [28]. The 
presence of an additional isomerization following the fast ligand binding step       
           is 
not justified based on this hyperbolic Zn
2+
-concentration-dependence of the      (see below), as this 
may occur too fast to be detected. When we consider the dissociation kinetics of PS, the presence of 
an isomerization step       
          as observed for the WT before the peripheral Zn
2+
 completely 
dissociated may be justified. This two-step dissociation most likely originates from a tighter complex, 
similar to the WT but albeit different structurally. Therefore, we propose the reaction mechanism in 
Scheme 2 for Zn
2+
 binding to PS stringently based on the observable ‘on’ rate.       
   and       
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are the ‘swivel open’ and ‘swivel closed’ conformers of the PS CTD, respectively where       
    is 
the ‘swivel compact closed’ state (CSM for central site mutant represents the PS construct, so as to 
avoid confusion with the PS used to represent the peripheral sites in all the kinetic schemes) (Figure 
9). At lower Zn
2+
 concentration, the binding of Zn
2+
 is limited by the presence of       
   and hence 
the transition from       
   to       
   contributes to     . At very high Zn
2+
 concentration the 
formation of       
           is fast and      is dominated by      
       
       
        
   and 
will approach the net rate constant of this isomerization step. We further reason that the binding steps 
are faster than isomerization based on the relatively slow dissociation kinetics and the high affinity 
binding of Zn
2+
 to the mutant (ITC results, Table 5), hence at high Zn
2+
 concentration,      
  
     
                    
  
      
  
 . Therefore, in accordance with such a mechanism, Equation 3 
can predict such an hyperbolic dependence on the Zn
2+
 concentration of decreasing observed rate 
constant (see Appendix S1 for the derivation of Equation 3 for this kinetic model, based on [29]): 
k
obs
= k
+csm
s + k
-csm
s KCSM
PS
K
CSM
PS + [Zn2+ ]
æ
è
ç
ö
ø
÷                   (Equation 3) 
We note that at lower concentration ([Zn
2+
] < 40 M) the transients of PS were not sufficiently 
qualitative with respect of signal to noise to attain good fitting while keeping peripheral sites under 
pseudo-first order reaction conditions and getting a reasonable fluorescence intensity. Therefore, fits 
were performed in the range of [Zn
2+
] > 40 M (Figure 8D, Table 6). This does not, however, change 
the assumption leading to the above mechanism. The ‘swivel open’ transition to ‘swivel closed’ is 
relatively fast (Table 6,      
  = 29.4 ± 1.6 sec
-1
), but slower than the actual binding, reflecting the 
lack of steric repulsions in the structure. Interestingly, the dynamics between the swivel open and 
swivel closed conformations within PS are much more apparent in solution as revealed by the kinetics 
and MD than observed by the structural studies, emphasizing the benefits of such measurements. The 
equilibrium constants indicate that the swivel open conformation is only slightly more favorable than 
the swivel closed (    
  = 0.45  0.27). The amplitudes determined from Zn2+ binding to PS (Figure 
8E) produce a        = 39.5  2.2 M but a stronger Hill coefficient    = 2.1  0.2 (fitted to the 
range of Amp increase, Table 6). The loss of amplitudes at higher Zn
2+
 concentration is due to the loss 
of the fast component in the binding reaction where the ‘swiveling’ isomerization dominates the 
amplitude. The larger Hill coefficient suggests that the closure of the protomers by binding at the 
central site before binding at the peripheral sites occurs, is key to increase allostery in the peripheral 
sites.  
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Discussion 
 
A new mode of metal binding to MamM CTD 
The major impact of this work is the underlying mechanism of Zn
2+
 binding to MamM CTD via three 
putative metal binding sites. Taken together, these results, in terms of structure, thermodynamics and 
kinetics, suggest a model in which one Zn
2+ 
ion readily binds, with fast kinetics, minimal energetic 
cost and very minor conformational changes to the central site. The ion binding changes the 
electrostatic properties of the binding cleft, which may however have a long-range effect on the 
peripheral sites as discussed below. This is followed by binding of an additional two Zn
2+
 ions, most 
likely simultaneously within the time regime of msec, to the peripheral sites, with slower kinetics as 
compared to the central site binding, at a larger energetic cost and with major conformational changes 
(Figure 9). Several lines of evidence are provided by using multiple approaches and dissection of site-
specific mutant data in comparison to the WT. The PS and the CS constructs each provide separate 
but limited contributions to the overall mechanism since not everything can be experimentally 
measured with the perturbation of the central and the peripheral binding sites, respectively. The PS 
mutant provides a unique insight into the flexibility of the dimerization domain between the two 
monomers. When binding to the peripheral sites occurs, it seems that at very high Zn
2+
 concentration, 
a decrease in the observable rate is also associated with a decrease in the fluorescence intensity which 
may reflect intermolecular swiveling of the monomer similar but quite not identical to WT. So, in 
other words, the two domains are able to swivel along a perpendicular axis (Figure 9), as was 
proposed, but not experimentally demonstrated, previously [13]. In addition, in the PS mutant, the Hill 
coefficient was determined from the amplitudes of Zn
2+
 binding kinetics which points to the central 
site’s tight closure contributing to an increase in allostery of Zn2+ peripheral site binding in 
comparison to the WT.  
 
Fast Zn
2+
 binding to the central site has no energetic cost and facilitates the binding to the 
peripheral site   
CS reveals no heat capacity change in the ITC binding experiments within the same range of Zn
2+
 
concentration as for WT and PS, suggesting that binding to the central site occurs with only minor 
conformational changes. Zn
2+
 binding in CS also results in a minor fluorescence spectral shift yet a 
large increase in the fluorescence intensity. The PELDOR results suggest that although exhibiting a 
different distance range as compared to the apo form, the CS does not adopt a closed, distinct 
conformation when Zn
2+
 is added. In CS, it is more probable that entropy decreases due to the more 
ordered zinc ions bound at the central site. Furthermore, enthalpy is also slightly decreased, in a way 
that leads to nearly no net overall change in the Gibbs free energy of the system. This is further 
supported by the WT and PS ITC results which indicate that in equilibrium their energetic parameters 
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are very similar. As their final states are expected to be similar,  binding to the central site does not 
contribute much to the overall heat change of the system. In terms of structural changes, one Zn
2+
 
binds initially to the central site residues of only one monomer (nonspecifically), which occurs very 
fast (<1.5 msec, as resolved from the WT kinetic results). The binding of one such ion could 
potentially change the local electrostatic surface, driving the second monomer to close the binding site 
thus neutralizing the positive charge. Our results, however, indicate that binding at the central site 
only leads to minor conformational changes and the protein remains in a dynamic, open state. This is 
only altered when the peripheral sites are occupied, leading to the tighter, locked state (Figure 9), as 
evidenced from the PS and WT fluorescence and PELDOR results.  
 
PS exhibits a different initial conformation and [Zn
2+
]-dependent movement as compared to WT 
The  value derived from ITC experiments of the WT and the PS mutants reflects the number of 
bound Zn
2+
 ions. These  values that were calculated from the ITC data indicate that the peripheral 
sites bind two ions (    = 2.4), hence the central site populates only one Zn
2+
 ion (    = 2.8,    
could not be calculated), which is lower than previous published results (NWT=4) [13]. PS exhibits a 
slightly lower  than WT, however, it has a twofold tighter    than WT (lower   ), suggesting that 
the binding occupies less sites but with a tighter affinity. This can also be inferred from the PELDOR 
results where both a less dynamic conformation and/or a shorter smaller distance distribution for the 
apo PS is observed as compared with the apo WT, as well as a reduction in the number of bound Zn
2+
 
ions. Structurally, this can be reasoned by a swiveling movement of the PS dimer (relative to the 
dimerization interface at the bottom of the V-shape) (Figure 9). Hence, and as was supported by the 
MD results, PS adopts a scissor-like conformation instead WT’s V-shape apo conformation. This 
would suggest that the initial states of the two apo forms are different and hence their binding 
mechanism is different. In the final state both WT and PS involve the binding of Zn
2+
 in the two 
peripheral sites and adopt a more similar conformation as compared to their initial states, which is 
supported by both the fluorescence and PELDOR results. These different initial states are not 
reflected in crystal structure models of the apo forms which are likely restrained by crystal contacts. 
Further, the only apo crystal structure which could not be detected is that of PS-C267S, further 
supporting that it might adopt a different conformation.  
 
Comparison of MamM CTD metal binding sites and conformational changes to other CDF 
proteins’ CTDs suggests a complex regulation mechanism in CDF proteins  
A comparison of our results in the wider context of the whole CDF protein family in terms of the 
binding sites and conformational changes observed in this study reveal further significant structural 
insights within the known CDFs’ CTDs bound structures (Figure 10A). The evolutionary-closest CDF 
CTD structure that was solved in a Zn
2+
-bound state is of MamB, another iron transporter CDF 
protein from MTB [14] (Figure 10B). Zn
2+
 in the MamB structure is chelated by D247 (homologous 
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to D249 in MamM), H283 (homologous to H285 in MamM) and H245 (found in the same location as 
W247 in MamM) (Figure 10C). Since MamM and MamB CTD sequences are highly conserved 
[14,17], MamB’s crystal structure strengthens the evidence for the ability of MamM’s central site to 
bind metals. However, in MamB, no conformational changes have yet been detected in the metal-
bound state compared the apo structure (Figure 10B). This could be due to two reasons: (1) Zn
2+
 was 
only soaked into the crystals after their formation [14], a method that may not invoke significant 
further conformational changes due to pre-existing strong crystal contacts. (2) The MamB structure 
does not involve Zn
2+
 binding at a peripheral site (which contains aspartate and threonine residues 
rather than the histidine and glutamate residues found in MamM), which has been shown here to 
induce such major conformational changes. 
All other CDF structures that were solved are of bacterial Zn
2+
 transporters (Figure 10D). CzrB is the 
only CDF protein whose CTD structure has been solved in both the apo and bound-closed forms. 
CzrB structures exhibit much larger conformational change between the apo and the bound-closed 
states [12] when compared to the degree-of-closure indicated by the PELDOR results for MamM. 
Moreover, the metal binding sites are not completely conserved between MamM and CzrB. The 
peripheral site of MamM involves H264 from one monomer and E289 from the other. In CzrB, one of 
the Zn
2+
 ions is chelated by homologous histidine and glutamate residues that are found in the same 
positions (H258 and E282), but also by an additional histidine (H280, homologous to S287 in MamM) 
(Figure 10E). Additionally, there are two Zn
2+
 ions bound per monomer in CzrB, that do not involve 
homologous residues to those of MamM binding sites and which involve residues only from one 
monomer (E243, homologous to D249 in MamM, is found at a distance of 3.71 Å from one of these 
ions, a long distance for an expected strong electrostatic interaction, therefore it is not expected to 
contribute much to the binding of the ion in this site). However, one of these Zn
2+
 ions (namely the 
second Zn
2+
 ion) is also bound by E282 and by other residues that are involved in the binding of the 
third Zn
2+
 [12] (Figure 10D), suggesting a net of Zn
2+
-protein interactions that can lead to the stable 
binding of Zn
2+
 in the CzrB peripheral site. The first two Zn
2+
 ions discussed in the context of CzrB 
are also found in the same locations and are ligated by homologous residues in the bacterial CDF 
model protein YiiP, for which only its closed structure has been solved [9,10,30,31] (Figure 10D,E). 
Such a multiple-Zn
2+
-binding state is not possible in MamM as some of the homologous residues in 
MamM are not suited to metal binding, yet despite this both the CzrB and YiiP closed structures 
support the importance of the peripheral site residues for metal binding and conformational changes, 
as revealed in this study.  
The comparison between all CDFs CTDs’ structures and binding sites reveals a complex regulatory 
mechanism for CDF proteins. The Zn
2+
 transporters show a network of Zn
2+
 binding sites that 
includes the peripheral sites and extends towards the center of the proteins, while the iron transporter 
MamB binds ion only in the center of the V-shaped dimer. MamM contains both the central and 
peripheral sites, suggesting a double-safe mechanism for this specific protein compared to MamB, and 
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a different regulation mechanism compared to the Zn
2+
 transporters: one site allows rapid binding and 
a change of the charge distribution, which facilitates the binding to the second site. This allows the 
conformational lock-down that will lead to further transmembrane domain conformational changes 
and active transport. Previous in vivo studies of MamM showed that mutations in both the central and 
peripheral CTD binding sites lead to small variations in magnetosome size, number and magnetic 
response [13]. These rather small changes might suggest that although the regulation is important for 
normal function, the transport can occur even when this regulation path is defected, meaning that 
metal can diffuse to the transmembrane domain independently, yet less efficiently. However, even 
mutations in the conserved transmembrane transport site of MamM, which were shown previously in 
many CDF proteins to have a drastic influence on the proteins’ function, showed relatively small 
impact on magnetite formation [8,17]. Hence, we speculate that MamB somehow compensates 
MamM function as opposed to mutations in the CTD binding sites having only a minor impact on the 
protein function. 
All the known CDF proteins’ CTD structures support our key finding of the capability of the central 
site to bind metal readily without any further large conformational changes. In addition, binding to the 
peripheral sites affords the induction of conformational changes in the dimer. While the 
transmembrane transport site is conserved between the different CDF proteins (in terms of location 
and importance for function) which implies a similar transport mechanism [8,11], the apparent 
versatility in the binding sites and conformations between the proteins CTDs suggest diverse 
regulation mechanisms for different proteins. The fine tuning in the regulation might be evolution-
related, since more highly evolved organisms emerge more sophisticated and complex regulation 
mechanisms. For example, recent studies of eukaryotic CDF proteins (plant MTP proteins and human 
ZnT proteins) suggest that other elements such as a His-rich loop - a cytoplasmatic loop between two 
transmembrane helices that is not found in the structurally-characterized CDF proteins - might play a 
role in protein regulation [32,33]. Further biochemical and structural studies of CDF proteins that are 
not Zn
2+
 or Fe
2+
 transporters proteins, and of eukaryotic CDF proteins, would be required to decipher 
the evolutionary pathway of the regulation mechanism in CDF proteins.  
 
To conclude, the kinetics of the transport rate of the full length CDF protein has been previously 
studied by the detection of change in Zn
2+
 concentration inside a vesicle. Here for the first time the 
conformational dynamics and kinetics of the CTD upon Zn
2+
 binding have been directly studied, 
revealing a molecular mechanism for binding, including stoichiometry, allostery, energetics and the 
order of binding. The structure-function relationships revealed here demonstrate how metal binding to 
a CTD of a CDF protein leads to distinct conformational changes within this domain in solution, thus 
significantly strengthening previous evidence highlighting the importance of CTD for overall protein 
regulation and function.   
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Materials and Methods 
 
Site-directed mutagenesis and protein expression. mamM CTD gene (UniProt Q6NE57 residues 215-
318) was previously cloned into pET28a(+) vector (Novagen, Merck Biosciences, Darmstadt, 
Germany) [34]; in this construct, pET28a-MamM-CTD-MSR1, the mamM gene was fused in-frame to 
express a six-His tag at the N-terminus of the protein followed by a thrombin proteolysis site. All 
MamM CTD mutations were applied to the pET28a-MamM-CTD-MSR1 vector using the 
QuickChange site-directed mutagenesis method (Stratagene, La Jolla, CA, USA). Primers containing 
single mutation sites (Hylabs, Rehovot, Israel) were designed and used for PCR amplifications. All 
MamM CTD forms were expressed similarly to previously described for MamM CTD WT [34]: E. 
coli Rosetta(DE3)pLysS strain cells (Novagen) harboring the pET28a-MamM-CTD-MSR1 plasmid 
were grown in auto-induction medium [35] containing kanamycin (100 mg mL
-1
) and 
chloramphenicol (30 mg mL
-1
) at 310 K for 6 hours. The cultivation temperature was then reduced 
from 310 to 300 K for a further 18 hours. The cells were harvested by centrifugation at 7438g for 8 
min at 277 K. 
 
Protein purification. All proteins used in this study were purified similarly to previously described 
for MamM CTD
 
M250L mutant [19,34]. All MamM CTD forms expressing cells were suspended in 
binding buffer containing 50 mM Tris-HCl pH=8, 300 mM NaCl, 20 mM imidazole, 5 mM β-
mercaptoethanol and 0.01% Triton X-100 at a weight ratio of 1:2, with DNaseI (10 μg mL-1) and a 
protease inhibitor cocktail (containing 100 μM phenylmethylsulfonyl fluoride (PMSF), 1.2 μg mL-1 
leupeptin and 1 μM pepstatin A) for 30 min at 277 K. The cells were then disrupted by three cycles of 
French press pressure cell (Thermo Scientific, Waltham, MA, USA) at 207 MPa. Cell debris was 
separated by centrifugation at 45,000 RPM (60 Ti fixed angle rotor, Beckman Coulter, Brea, CA, 
USA) for 45 min at 277 K and the soluble fraction was applied onto a home-made gravity Ni-NTA 
column (2.5 cm diameter Econo-Column by Bio-Rad, Hercules, CA, USA; 5 mL bed volume of 
HisPur Ni-NTA resin by Thermo Scientific) pre-equilibrated with the binding buffer. Protein were 
washed with 50 mL of two washing buffers for further purification, containing: (1) 20 mM Tris-HCl 
pH=8, 1 M NaCl, 40 mM imidazole and 5 mM β-mercaptoethanol, (2) 20 mM Tris-HCl pH=8, 150 
mM NaCl, 40 mM imidazole and 5 mM β-mercaptoethanol, and eluted with buffer containing 20 mM 
Tris-HCl pH=8, 150 mM NaCl, 500 mM imidazole and 5 mM β-mercaptoethanol. To remove the six-
His tag, bovine thrombin (10 U mL
-1
; t4648-10KU, Sigma-Aldrich, St. Louis, MO, USA) was added 
to the eluted protein and the mixture dialyzed against the final buffer, containing 10 mM Tris-HCl 
pH=8, 150 mM NaCl and 5 mM β-mercaptoethanol for 16 hours at 277 K. Protein was then 
concentrated to a volume of 4 mL using a Vivaspin-4 (3000 Da MW cutoff; Sartorius Stedim Biotech 
GmbH, Goettingen, Germany) and applied onto a size-exclusion column (HiLoad 26/60 Superdex 75; 
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GE Healthcare Biosciences, Danyel Biotech Ltd., Rehovot, Israel) pre-equilibrated with the final 
buffer. Selected peaks of pure protein were collected and concentrated using a Vivaspin-4 to a final 
concentration of 10-60 mg mL
-1
, flash-frozen in liquid nitrogen and stored at 193 K for further use. 
Throughout the purification process, protein concentration was determined by measuring absorption 
at 280 nm, and protein purity was analyzed by SDS-polyacrylamide gel electrophoresis (PAGE). For 
all C267S constructs, β-mercaptoethanol was not used during purification and in the final storage 
solutions. For all further experiments, protein concentration was also determined by measuring 
absorption at 280 nm. 
 
Crystallization and structure determination. Purified MamM CTD proteins: W247A in buffer 
containing 10 mM Tris pH=8.0, 150 mM NaCl, and 5 mM β-mercaptoethanol;  CS in buffer 
containing 10 mM Tris pH=8.0, 150 mM NaCl, 3.375 mM MnCl2 and 5 mM β-mercaptoethanol;  CS-
C267S and C267S in buffer containing 10 mM Tris pH=8.0, 150 mM NaCl (buffer A); were 
crystallized using the vapor diffusion method at 293 K (0.3 μL protein with a 0.3 μL reservoir 
solution for all proteins but CS, where 1 μL protein with 1 μL reservoir solution were used). Crystals 
were harvested with or without treatment of cryo agent and flash-frozen in liquid nitrogen. Data 
collection was performed on a single-crystal at a temperature of 100 K. All cryo conditions, data 
collection details, data reduction and scaling, phasing and refinement details are given in Tables 1-3.  
 
Least-squares overlaps. MamM CTD structures were overlaid and RMSDs calculated using the 
iterative magic fit tool of Swiss-PdbViewer 4.1.0 [36]. All MamM CTD structures and all overlapped 
structure figures were prepared using UCSF Chimera package, version 1.12 [37]. 
 
Circular dichroism measurements. CD measurements were performed using a J750 
spectropolarimeter (Jasco Inc, Easton, MD, USA) at ambient temperature. MamM CTD proteins were 
incubated with EDTA for 5 hours, which was subsequently removed by dialysis. The proteins were 
diluted to a final concentration of 0.3 mg mL
-1
, with or without Zn
2+
 (15:1 Zn
2+
 to protein ratio), in a 
buffer containing 10 mM Tris-HCl pH=8, 50 mM NaCl and 0.188 mM β-mercaptoethanol, and 
measured with a 0.1 cm optical path Suprasil quartz cuvette (Hellma GmbH & Co., Müllheim, 
Germany). Spectra profiles of the samples were measured in a wavelength range of 200-260 nm, with 
a bandwidth of 1 nm, a scan speed of 5 nm min
-1
 and a time constant of 8 sec. 
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Site-directed spin labelling. For site-directed spin labelling, protein solutions in buffer A (containing 
10 mM Tris-HCl pH=8 and 150 mM NaCl) were degassed under argon and treated with degassed 1,4-
Dithiotheitol (DTT, 1 mM) for 4 hours at 4 
o
C with gentle agitation. Subsequently, protein samples 
were washed once using Zeba
TM
 Spin desalting columns (7 kDa MWCO, 2 mL; Thermo 
ScientificFisher, Waltham, MA, USA) and degassed buffer A. Protein was then labelled overnight at 
4 
o
C with (1-oxyl-2,2,5,5-tetramethylpyrrolidin-3-yl)methylthiosulfonate spin label (MTSL, 20x 
excess) (Toronto Research Chemicals Inc., North York, Ontario, Canada) under gentle agitation. To 
remove excess unbound MTSL, samples were washed twice using Zeba
TM
 Spin desalting Columns 
and degassed buffer A. 
 
Pulsed electron-electron double resonance measurements. Spin-labelled variants were lyophilised 
before being taken up in D2O to a final concentration of 150-200 μM, and EPR samples (both apo and 
Zn
2+
-containing) were prepared with 30 % Glycerol-d8 (Sigma-Aldrich). For Zn
2+
-containing samples, 
ZnCl2 stock solutions were prepared in buffer A (in D2O). Each spin-labelled variant C267S, PS-
C267S and CS-C267S was incubated with a 5-fold excess of Zn
2+
 for 1 hour at room temperature, 
then Glycerol-d8 was added. A 100 μL sample was loaded into an EPR quartz tube (Wilmad SQ-707; 
Wilmad-LabGlass, Vinland, NJ, USA) and flash frozen in liquid nitrogen. For the titration experiment 
of the C267S variant, the previously measured apo sample was first thawed slowly over liquid-N2 and 
removed from its EPR tube to an eppendorf. Zn
2+
 was then added (1x excess) and the sample was 
allowed to incubate at room temperature for approximately 2 hours before transferring back into the 
tube, flash freezing and re-measuring. This was repeated for Zn
2+
 excesses of 2x, 3x, 4x, 5x, 6x, 8x, 
and 10x using the same sample. The same experimental approach was taken for the titration 
experiment of the PS-C267S variant, this time with Zn
2+
 excesses of 1x, 2x, 3x and 5x. X-band pulsed 
EPR spectra were recorded on a Bruker E580 spectrometer (Bruker, Rheinstetten, Germany) using a 
Bruker MD5-W1 EPR probehead equipped with a self-modified cryogen-free cryostat (Advanced 
Research Systems Inc, Macungie, PA, USA). The microwave pulses were amplified using a 1kW-
TWT (Applied Systems Engineering Inc., Fort Worth, TX, USA). All EPR experiments were carried 
out at 60K. The field-swept spectrum was obtained by integrating the Hahn echo signal as a function 
of the magnetic field after a two-pulse sequence.  
For the 4-pulse PELDOR experiments recorded at 60 K, pulse lengths were 20 nsec for π/2 and 20 
nsec for π. The pump pulse length was 16 nsec and ∆ν (νobs – νpump) was 70 MHz. The pulse separation 
τ1 was 352 nsec (C267S apo), 386 nsec (CS-C267S apo) or 120 nsec (all others), while τ2 varied 
between 2000-4000 ns, and the echo signals were integrated using a video amplifier bandwidth of 20 
MHz. The pump pulse was stepped out by 16 nsec for a total number of points in T that depended 
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upon the τ2 used. Nuclear modulation artifacts were suppressed using a systematic variation of the 
interpulse delay time τ1 and an appropriate phase cycling routine.  
 
Molecular dynamics and principal component analysis. All MD simulations were performed using 
the NAMD molecular dynamics software version 2.13b2 [38]. The CHARMM 36/CMAP force field 
[39] with TIP3P water model [40] was used to describe the system. 
During simulations, a time step of 2 fsec was used. In all simulations, periodic boundary conditions 
with the particle mesh Ewald algorithm for electrostatics were employed [41]. All simulations were 
performed under the same conditions: temperature was held constant using Langevin dynamics at 300 
K with a damping coefficient, 1 psec
−1
; pressure was held constant using Langevin piston method at 1 
atm also with a damping coefficient, 1 psec
−1
, piston's oscillation period to 100 fsec and pistons decay 
time of 50 fsec; switching and cutoff distances, 1 nm and 1.2 nm, respectively; pairlist distance, 1.4 
nm. 
System preparation was done using the VMD software package version 1.93 [42]. Initial models of 
WT and PS were based on the PDB IDs: 3W5X and 3W66, respectively [13]. All simulated proteins 
were solvated into a water box with a minimum solvation shell of 14 Å thickness. Simulated systems 
were then neutralized by adding counter ions at random positions. Before initiating free MD 
simulations, all systems were minimized and equilibrated. Initially, each system was submitted to 10K 
steps of conjugate gradient minimization where protein’s heavy atoms are positionally restrained. This 
minimization was followed by two steps of equilibration. First, each system was heated to 300 K 
while simulated for 200 psec under NVT conditions with the solute’s heavy atoms restrained. 
Secondly, each system was simulated using the NPT ensemble for 200 nsec while restraints are 
gradually removed. Finally, each system was submitted to free NPT 200 nsec length MD simulations. 
Analyses were performed using GROMACS version 2018.1 [43]. Analyses were performed on the 
productive stage of the simulations (i.e. after the first 20 nsec). For the root mean square deviation 
(RMSD) analysis, the positional deviations of backbone heavy atoms (N, Cα, C), with respect to their 
initial structure, were calculated every 10 psec (after performing a least square fit to their initial 
structure). For fluctuation profile analysis, fluctuations of backbone heavy atoms (N, Cα, C and O) 
with respect to their initial structure were calculated every 10 psec (after performing a least square fit 
to their initial structure). 
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All visualization was done using the PyMOL Molecular Graphics System, Version 2.3 (Schrödinger, 
LLC.). Principle movements were drawn using the modevectors.py script by Sean M. Law. 
 
Isothermal titration calorimetry measurements and analysis. ITC measurements were performed in 
low-volume Nano ITC calorimeter (TA Instruments, New Castle, DE, USA) at 298 K. Proteins were 
prepared in buffer A and Zn
2+
 solutions in buffer containing 1 mM Tris pH=8 and 150 mM NaCl. All 
proteins were diluted to 50 µM and titrated with: Zn
2+
 1.4 mM (WT), Zn
2+
 1 mM (PS) or Zn
2+
 750 µM 
(CS). The protein samples were injected into the instrument cell (170 µL) and 20 aliquots of 2.5 µL of 
a suitable ZnCl2 solution were titrated into the cell every 350 seconds. For each protein, 3 independent 
titrations were recorded. As a control, each ZnCl2 solution was also titrated into buffer A under 
identical experimental conditions, and all measurements were compared to a Double-distilled water-
containing reference cell. Data were analyzed using TA NanoAnalyze Data Analysis software, 
version 3.7.5 (TA Instruments, New Castle, DE, USA). For WT and PS, data for each measurement 
was fitted after reduction of the control to an independent model combined with a blank constant 
model, and the thermodynamics values determined are the average of three different titrations for each 
protein. Errors are reported as the standard deviation. 
 
Fluorescence spectrometry measurements and analysis. Changes in tryptophan intrinsic 
fluorescence were monitored using a Fluorolog
®
-3 (HORIBA Scientific, Edison, NJ, USA) equipped 
with 1cm optical path length quartz cell at ambient temperature. 1mL samples MamM CTD proteins 
at 5 µM in buffer A were titrated using a 1 mM ZnCl2 solution in the same buffer to reach different 
Zn
2+
 concentrations. Samples were measured at an excitation of λex 297 nm, and the emission 
spectrum for each Zn
2+
 concentration recorded between 310-450 nm. Each protein-metal titration was 
replicated three times, and each spectrum was fitted to an extreme function using OriginPro (R-Square 
(COD) > 0.98) (OriginLab Corporation, Northampton, MA, USA). The maximum wavelength 
(wavelength of maximum intensity) and the intensity at that wavelength (aka maximum intensity) 
were averaged for each Zn
2+
 concentration. Errors are reported as the standard deviation. 
 
Stopped-flow measurements and analysis. Stopped flow experiments were performed using a 
temperature-controlled Tech Scientific SF-61DX2 stopped-flow instrument (TgK Scientific Ltd., 
Bradford-on-Avon, UK) at 298 K. All proteins, Zn
2+
 and EDTA solutions were prepared in buffer A. 
Proteins at 5 µM initial concentration were injected at a 1:1 ratio with Zn
2+
 solutions (40-460 µM 
initial concentrations for WT, 30-460 µM initial concentrations for PS) into the 20 µL reaction cell. 
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For the dissociation experiment, protein at 5 µM pre-equilibrated with 300 µM Zn
2+
 was injected in a 
1:1 ratio with 2 mM / 5 mM EDTA solutions (initial concentrations) into the 20 µL reaction cell. 
Samples were excited at λex 297 nm and the tryptophan fluorescence signal was recorded through a 
long-pass 320 nm filter. For each injection, 2000 data points were collected for 10 sec at logarithmic 
time scale containing 10 cycles of 200 points/cycle.  
For the association measurements of MamM CTD with Zn
2+
 n=2 was used, while for the dissociation 
measurements of the MamM CTD - Zn
2+
 with EDTA n=1 was used, where n is the number of 
independent measurements (different protein and Zn
2+
 stocks and initialized instrument; in each 
measurement of protein-Zn
2+
 or protein-Zn
2+
-EDTA ratio, at least three injections were averaged). 
Data were averaged and analyzed using the Kinetic Studio software provided with the instrument or 
with OriginPro. Time-dependent changes of the fluorescence signal were fitted to the exponential 
function given in Equation 4: 
1
( ) i
n k t
ii
F t F A e

 
               (Equation 4) 
Where F(t) is the fluorescence signal at time t, F∞ is the signal at t10sec, Ai is the amplitude, ki is the 
observed rate constant, i represents the i
th
 relaxation processes, and n is the total number of relaxation 
processes, which is either 1 (for a single exponential, e.g. for PS and WT) or 2 (for a double 
exponential, dissociation experiments). Data were fitted in the time range 1.5 - 200 msec for PS or 1.5 
- 500 msec for WT for a single exponential, or in time range of 0.0015 - 10 sec for the double 
exponential EDTA experiments, to exclude the continuous-flow phase of mixing and the tryptophan 
photobleaching phase.  
 
Author Contributions 
 
All authors designed the study, analyzed the results and wrote the paper. SBZ and JH conducted the 
experiments, IK performed the MD simulations and MVS assisted with kinetic modeling. All authors 
approved the final version of the manuscript. 
 
Acknowledgments  
 
We thank Dr. Anat Shahar for her help with the crystallographic data collection and analysis, to Dr. 
Tamar Kurzion-Zilbermann for her assistance in CD measurements, to Geula Davidov and to Dr. 
Nitzan Kutnowski for their help with the ITC measurements and to Prof. Ofer Yifrach for fruitful 
discussion. SBZ and RZ are supported by the Israel Ministry of Science, Technology and Space; the 
Israel Science Foundation (grant no. 167/16); the European Molecular Biology Organization and the 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
EU (CMST COST Action CM1306 Understanding Movement and Mechanism in Molecular 
Machines). This work was supported in part by the Royal Society (FM was a Wolfson Research Merit 
Award Holder); the EU (COST Action CM1306 Understanding Movement and Mechanism in 
Molecular Machines) to FM. JH was supported by the BBSRC Norwich Research Park Biosciences 
Doctoral Training Partnership grant number BB/M011216/1. AH and MVS are supported by the 
Israel Science Foundation (grants 296/13) and Marie Curie Career Integration Award to AH (grants 
1403705/11). Finally, we thank Geffen Zucker for being an integral part of this work and influencing 
every part of it. 
 
References 
 
1 Laity JH, Lee BM & Wright PE (2001) Zinc finger proteins: new insights into structural and 
functional diversity. Curr Opin Struct Biol 11, 39–46. 
2 Cox N, Retegan M, Neese F, Pantazis DA, Boussac A & Lubitz W (2014) Photosynthesis. 
Electronic structure of the oxygen-evolving complex in photosystem II prior to O-O bond 
formation. Science 345, 804–808. 
3 Kanteev M, Goldfeder M & Fishman A (2015) Structure-function correlations in tyrosinases. 
Protein Sci 24, 1360–1369. 
4 Dupureur CM (2008) Roles of metal ions in nucleases. Curr Opin Chem Biol 12, 250–255. 
5 Berg OG & von Hippel PH (1985) Diffusion-controlled macromolecular interactions. Annu Rev 
Biophys Biophys Chem 14, 131–160. 
6 Dudev T & Lim C (2014) Competition among Metal Ions for Protein Binding Sites: Determinants 
of Metal Ion Selectivity in Proteins. Chem Rev 114, 538–556. 
7 Montanini B, Blaudez D, Jeandroz S, Sanders D & Chalot M (2007) Phylogenetic and functional 
analysis of the Cation Diffusion Facilitator (CDF) family: improved signature and prediction of 
substrate specificity. BMC Genomics 8, 107. 
8 Kolaj-Robin O, Russell D, Hayes K a., Pembroke JT & Soulimane T (2015) Cation Diffusion 
Facilitator family: Structure and function. FEBS Lett 589, 1283–1295. 
9 Lu M, Chai J & Fu D (2009) Structural basis for autoregulation of the zinc transporter YiiP. Nat 
Struct Mol Biol 16, 1063–1067. 
10 Lopez-Redondo ML, Coudray N, Zhang Z, Alexopoulos J & Stokes DL (2018) Structural basis for 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
the alternating access mechanism of the cation diffusion facilitator YiiP. Proc Natl Acad Sci 
115, 3042–3047. 
11 Barber-Zucker S, Shaanan B & Zarivach R (2017) Transition metal binding selectivity in proteins 
and its correlation with the phylogenomic classification of the cation diffusion facilitator protein 
family. Sci Rep 7, 16381. 
12 Cherezov V, Höfer N, Szebenyi DME, Kolaj O, Wall JG, Gillilan R, Srinivasan V, Jaroniec CP & 
Caffrey M (2008) Insights into the mode of action of a putative zinc transporter CzrB in 
Thermus thermophilus. Structure 16, 1378–1388. 
13 Zeytuni N, Uebe R, Maes M, Davidov G, Baram M, Raschdorf O, Nadav-Tsubery M, Kolusheva 
S, Bitton R, Goobes G, Friedler A, Miller Y, Schüler D & Zarivach R (2014) Cation diffusion 
facilitators transport initiation and regulation is mediated by cation induced conformational 
changes of the cytoplasmic domain. PLoS One 9, e92141. 
14 Uebe R, Keren-Khadmy N, Zeytuni N, Katzmann E, Navon Y, Davidov G, Bitton R, Plitzko JM, 
Schüler D & Zarivach R (2018) The dual role of MamB in magnetosome membrane assembly 
and magnetite biomineralization. Mol Microbiol 107, 542–557. 
15 Barber-Zucker S & Zarivach R (2017) A Look into the Biochemistry of Magnetosome 
Biosynthesis in Magnetotactic Bacteria. ACS Chem Biol 12, 13–22. 
16 Uebe R & Schüler D (2016) Magnetosome biogenesis in magnetotactic bacteria. Nat Rev 
Microbiol 14, 621–637. 
17 Uebe R, Junge K, Henn V, Poxleitner G, Katzmann E, Plitzko JM, Zarivach R, Kasama T, Wanner 
G, Pósfai M, Böttger L, Matzanke B & Schüler D (2011) The cation diffusion facilitator proteins 
MamB and MamM of Magnetospirillum gryphiswaldense have distinct and complex functions, 
and are involved in magnetite biomineralization and magnetosome membrane assembly. Mol 
Microbiol 82, 818–835. 
18 Zeytuni N, Uebe R, Maes M, Davidov G, Baram M, Raschdorf O, Friedler A, Miller Y, Schüler D 
& Zarivach R (2014) Bacterial magnetosome biomineralization-a novel platform to study 
molecular mechanisms of human CDF-related Type-II diabetes. PLoS One 9, e97154. 
19 Barber-Zucker S, Uebe R, Davidov G, Navon Y, Sherf D, Chill JH, Kass I, Bitton R, Schüler D & 
Zarivach R (2016) Disease-Homologous Mutation in the Cation Diffusion Facilitator Protein 
MamM Causes Single-Domain Structural Loss and Signifies Its Importance. Sci Rep 6, 31933. 
20 Jeschke G (2016) Dipolar Spectroscopy - Double-Resonance Methods. In eMagRes (Ashbrook S), 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
pp. 1459–1476. John Wiley & Sons, Ltd, Chichester, UK. 
21 Jeschke G (2012) DEER Distance Measurements on Proteins. Annu Rev Phys Chem 63, 419–446. 
22 Jeschke G (2018) MMM: A toolbox for integrative structure modeling. Protein Sci 27, 76–85. 
23 Jeschke G, Chechik V, Ionita P, Godt A, Zimmermann H, Banham J, Timmel CR, Hilger D & 
Jung H (2006) DeerAnalysis2006—a comprehensive software package for analyzing pulsed 
ELDOR data. Appl Magn Reson 30, 473–498. 
24 David CC & Jacobs DJ (2014) Principal Component Analysis: A Method for Determining the 
Essential Dynamics of Proteins. In Methods in molecular biology (Livesay D, ed), pp. 193–226. 
Humana Press, Totowa, NJ. 
25 Ichiye T & Karplus M (1991) Collective motions in proteins: A covariance analysis of atomic 
fluctuations in molecular dynamics and normal mode simulations. Proteins Struct Funct Genet 
11, 205–217. 
26 Amadei A, Linssen ABM & Berendsen HJC (1993) Essential dynamics of proteins. Proteins Struct 
Funct Genet 17, 412–425. 
27 Xiao Z & Wedd AG (2010) The challenges of determining metal–protein affinities. Nat Prod Rep 
27, 768–789. 
28 Fersht A (1999) Measurement and Magnitude of Individual Rate Constants. In Structure and 
mechanism in protein science : a guide to enzyme catalysis and protein folding (Hadler GL, ed), 
pp. 148–153. W.H. Freeman and Company, NY. 
29 Hannemann DE, Cao W, Olivares AO, Robblee JP & De La Cruz EM (2005) Magnesium, ADP, 
and Actin Binding Linkage of Myosin V: Evidence for Multiple Myosin V−ADP and 
Actomyosin V−ADP States. Biochemistry 44, 8826–8840. 
30 Coudray N, Valvo S, Hu M, Lasala R, Kim C, Vink M, Zhou M, Provasi D, Filizola M, Tao J, 
Fang J, Penczek P a, Ubarretxena-Belandia I & Stokes DL (2013) Inward-facing conformation 
of the zinc transporter YiiP revealed by cryoelectron microscopy. Proc Natl Acad Sci U S A 110, 
2140–2145. 
31 Lu M & Fu D (2007) Structure of the zinc transporter YiiP. Science 317, 1746–1748. 
32 Fukue K, Itsumura N, Tsuji N, Nishino K, Nagao M, Narita H & Kambe T (2018) Evaluation of 
the roles of the cytosolic N-terminus and His-rich loop of ZnT proteins using ZnT-2 and ZnT-3 
chimeric mutants. Sci Rep 8, 14084. 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
33 Tanaka N, Fujiwara T, Tomioka R, Krämer U, Kawachi M & Maeshima M (2015) 
Characterization of the histidine-rich loop of arabidopsis vacuolar membrane zinc transporter 
AtMTP1 as a sensor of zinc level in the cytosol. Plant Cell Physiol 56, 510–519. 
34 Zeytuni N, Offer T, Davidov G & Zarivach R (2012) Crystallization and preliminary 
crystallographic analysis of the C-terminal domain of MamM, a magnetosome-associated 
protein from Magnetospirillum gryphiswaldense MSR-1. Acta Crystallogr Sect F Struct Biol 
Cryst Commun 68, 927–930. 
35 Studier FW (2005) Protein production by auto-induction in high-density shaking cultures. Protein 
Expr Purif 41, 207–234. 
36 Guex N & Peitsch MC (1997) SWISS-MODEL and the Swiss-PdbViewer: an environment for 
comparative protein modeling. Electrophoresis 18, 2714–2723. 
37 Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC & Ferrin TE (2004) 
UCSF Chimera-A visualization system for exploratory research and analysis. J Comput Chem 
25, 1605–1612. 
38 Phillips JC, Braun R, Wang W, Gumbart J, Tajkhorshid E, Villa E, Chipot C, Skeel RD, Kalé L & 
Schulten K (2005) Scalable molecular dynamics with NAMD. J Comput Chem 26, 1781–1802. 
39 Best RB, Zhu X, Shim J, Lopes PEM, Mittal J, Feig M & MacKerell AD (2012) Optimization of 
the Additive CHARMM All-Atom Protein Force Field Targeting Improved Sampling of the 
Backbone ϕ, ψ and Side-Chain χ 1 and χ 2 Dihedral Angles. J Chem Theory Comput 8, 3257–
3273. 
40 Jorgensen WL, Chandrasekhar J, Madura JD, Impey RW & Klein ML (1983) Comparison of 
simple potential functions for simulating liquid water. J Chem Phys 79, 926. 
41 Essmann U, Perera L, Berkowitz ML, Darden T, Lee H & Pedersen LG (1995) A smooth particle 
mesh Ewald method. J Chem Phys 103, 8577–8593. 
42 Humphrey W, Dalke A & Schulten K (1996) VMD: visual molecular dynamics. J Mol Graph 14, 
33–38, 27–28. 
43 Abraham MJ, Murtola T, Schulz R, Páll S, Smith JC, Hess B & Lindahl E (2015) GROMACS: 
High performance molecular simulations through multi-level parallelism from laptops to 
supercomputers. SoftwareX 1–2, 19–25. 
44 Kabsch W (2010) XDS. Acta Crystallogr D Biol Crystallogr 66, 125–132. 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
45 Otwinowski Z & Minor W (1997) Processing of X-ray diffraction data collected in oscillation 
mode. Methods Enzymol 276, 307–326. 
46 Evans PR & Murshudov GN (2013) How good are my data and what is the resolution? Acta 
Crystallogr Sect D Biol Crystallogr 69, 1204–1214. 
47 McCoy AJ, Grosse-Kunstleve RW, Adams PD, Winn MD, Storoni LC & Read RJ (2007) Phaser 
crystallographic software. J Appl Crystallogr 40, 658–674.. 
48 Murshudov GN, Skubák P, Lebedev AA, Pannu NS, Steiner RA, Nicholls RA, Winn MD, Long F 
& Vagin AA (2011) REFMAC5 for the refinement of macromolecular crystal structures. Acta 
Crystallogr D Biol Crystallogr 67, 355–367. 
49 Joosten RP, Long F, Murshudov GN & Perrakis A (2014) The PDB_REDO server for 
macromolecular structure model optimization. IUCrJ 1, 213–220. 
50 Adams PD, Afonine P V, Bunkóczi G, Chen VB, Davis IW, Echols N, Headd JJ, Hung L-W, 
Kapral GJ, Grosse-Kunstleve RW, McCoy AJ, Moriarty NW, Oeffner R, Read RJ, Richardson 
DC, Richardson JS, Terwilliger TC & Zwart PH (2010) PHENIX: a comprehensive Python-
based system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr 66, 
213–221. 
51 Emsley P, Lohkamp B, Scott WG & Cowtan K (2010) Features and development of Coot. Acta 
Crystallogr D Biol Crystallogr 66, 486–501. 
52 Winn MD, Ballard CC, Cowtan KD, Dodson EJ, Emsley P, Evans PR, Keegan RM, Krissinel EB, 
Leslie AGW, McCoy A, McNicholas SJ, Murshudov GN, Pannu NS, Potterton EA, Powell HR, 
Read RJ, Vagin A & Wilson KS (2011) Overview of the CCP4 suite and current developments. 
Acta Crystallogr D Biol Crystallogr 67, 235–242. 
 
  
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
Tables 
 
Table 1: Crystallization of MamM CTD mutants.  
 
Protein name 
MamM CTD 
C267S 
MamM CTD 
W247A 
MamM CTD 
H264A-E289A-
C267S 
MamM CTD 
H264A-E289A 
PDB ID 6G55 6G6I 6G5E 6G64 
Crystallization 
conditions 
0.2 M Li2SO4, 0.1 
M BIS-TRIS 
pH=5.5, 25% PEG 
3350 
0.1 M BIS-TRIS 
pH=5.5, 20% PEG 
3350 
0.2 M Li2SO4, 0.1 
M BIS-TRIS 
pH=5.5, 25% PEG 
3350 
0.2 M (NH4)2SO4, 
0.1 M BIS-TRIS 
pH=5.5, 22% PEG 
3350 
Cryo protectant - 50% PEG 3350 - - 
 
Protein 
concentration (mg 
mL
-1
) 
 
7.5 6.08 5 10 
Crystallization 
type 
 
Vapor diffusion sitting drop 
Data collection P13 - DESY ID29 - ESRF ID29 - ESRF Home source 
Detector Pilatus 6M Pilatus 6M Pilatus 69 MAR345 
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Table 2: Data collection and refinement statistics of MamM CTD mutants.  
 
Protein name 
MamM CTD 
C267S 
MamM CTD 
W247A 
MamM CTD 
H264A-E289A-
C267S 
MamM CTD 
H264A-E289A  
PDB ID 6G55 6G6I 6G5E 6G64 
Data collection P13 - DESY ID29 - ESRF ID29 - ESRF Home source 
Space group C 2 2 21 P21 21 21 C2 2 21 C 2 2 21 
Cell dimensions     
a, b, c (Å) 
37.31, 94.37, 
53.64 
38.65, 65.75, 
68.65 
37.03, 94.79, 
53.50 
37.11, 95.09, 
53.73 
α, β, γ (°) 90, 90, 90 90, 90, 90 90, 90, 90 90, 90, 90 
Resolution (Å) 
1.65-35.43 (1.65-
1.68) 
2.40-47.49 (2.40-
2.49) 
1.60-47.40 (1.60-
1.62) 
1.90-50.00 (1.90-
1.93) 
Rsym or Rmerge 0.044 (1.635) 0.193 (1.500) 0.029 (0.572) 0.042 (0.273) 
I/σI 16.8 (1.2) 9.7 (1.5) 26.9 (2.2) 48.5 (5.1) 
CC1/2 0.999 (0.636) 0.996 (0.665) 0.999 (0.931) 0.986 (0.892) 
Completeness (%) 99.5 (97.9) 99.7 (97.2) 99.2 (86.5) 97.2 (88.9) 
Redundancy 4.6 (4.5) 8.7 (8.7) 6.4 (5.8) 8.5 (4.0) 
Wavelength (Å) 0.97631 0.975 0.975 1.5406 
No. unique 
reflections 
11722 7305 12814 7559 
Refinement     
Resolution (Å) 1.65-35.43 2.40-47.49 1.60-35.48 1.90-47.54 
Rwork/Rfree 19.04/21.51 22.10/26.18 20.61/25.68 20.51/23.90 
No. atoms     
Protein A- 658, D-57 A-728, B-815 639 622 
Ligand/ion 14 4 10 14 
Water 41 23 52 53 
B-factors     
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Protein 
A- 39.861, 
D-76.573 
A-44.222, 
B-47.739 
34.768 25.620 
Ligand/ion 
SO4-43.610, BCT-
57.580 
βME-79.395 SO4-31.602 
SO4-32.880, βME-
52.630 
Water 43.445 34.486 40.492 30.642 
RMSD     
Bond lengths (Å) 0.014 0.006 0.006 0.013 
Bond angles (°) 1.602 1.09 0.805 1.598 
Ramachandran 
statistics 
a
 
P: 75 (98.68%), 
A: 1 (1.32%), O: 0 
(0%) 
P: 187 (98.42%), 
A: 3 (1.58%), O: 0 
(0%) 
P: 76 (98.70%), 
A: 1 (1.30%), O: 0 
(0%) 
P: 77 (98.72%), 
A: 1 (1.28%), O: 0 
(0%) 
Missing residues 
A- 211, 293-318, 
D- 211-306, 314-
318 
A: 307-318. B: 
211, 316-318 
293-318 211, 293-318 
 
a
 P- Preferred region, A- Allowed region, and O- outliers. 
Values in parentheses are for the highest resolution shell. 
One crystal was used per dataset. 
Data was collected at 100K. 
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Table 3: Crystallographic software used for solving the structure of MamM CTD mutants.  
 
Protein name 
MamM CTD 
C267S 
MamM CTD 
W247A 
MamM CTD 
H264A-E289A-
C267S 
MamM CTD 
H264A-E289A 
PDB ID 6G55 6G6I 6G5E 6G64 
Data reduction XDS [44] XDS XDS HKL2000 [45] 
Data scaling Aimless [46] Aimless Aimless HKL2000 
Structure solution 
method 
Molecular replacement – using MamM CTD WT structure (PDB ID: 3W5X) 
Phasing Phaser MR [47] 
Refinement 
Refmac5 [48],  
PDB-REDO [49] 
Phenix [50], PDB-
REDO 
Refmac5, Phenix 
Refmac5, PDB-
REDO 
 
Manual refinement was performed using Coot version 0.8.9 [51]. 
Aimless, Phaser MR and Refmac5 were used through the CCP4i package [52]. 
  
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
Table 4: RMSDs between crystal structures of the different MamM CTD constructs.  
 
Protein name WT – 3W5X WT – 3W5Y PS – 3W66 PS – 3W8P CS – 6G64 
WT – 3W5X - 0.82 0.88 1.04 0.19 
WT – 3W5Y - - 1.00 0.74 0.92 
PS – 3W66 - - - 0.97 0.90 
PS – 3W8P - - - - 1.11 
CS – 6G64 - - - - - 
 
RMSDs between structures (carbon alpha) were calculated using the iterative magic fit tool in 
SwissPdbViewer [36].  
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Table 5: Thermodynamic parameters of Zn
2+
 binding to WT and PS determined by ITC. 
 
Parameter WT 
a
 PS 
b
 
KD (M) 31.5  3.4 17.9  2.6 
N 2.80  0.24 (3-4) c 2.41  0.24 (2) c 
ΔH (kJ mol-1) -4.20  0.10 -5.42  2.36 
Kass (mM
-1
) 32.07  3.22 56.78  7.45 
-TΔS (kJ mol -l) -21.51  0.29 -21.69  2.34 
ΔG (kJ mol-1) -25.71  0.26 -27.11  0.34 
ΔS (J mol-1 K-1) 72.15  0.98 72.76  7.84 
 
a
 [WT]i = 50 M, [WT]f = 37.45 M, [Zn
2+
]i = 1.4 mM & [Zn
2+
]f = 351 M, ratio: 1:9.4 
b
 [PS]i = 50 M, [PS]f = 37.45 M, [Zn
2+
]i  = 1.0 mM  & [Zn
2+
]f = 251 M, ratio: 1:6.7  
c
 N values from PELDOR titrations. 
Data were fitted to independent + blank (constant) models in the TA NanoAnalyze Data Analysis 
software.  
Each parameter represents three independent measurements after control reduction (Zn
2+
 at the same 
concentration, titrated into buffer solution). Errors are reported as the standard deviation. 
In all measurements, the sample in cell was in 10 mM Tris-HCl pH 8.0 and 150 mM NaCl, while the 
titrant Zn
2+
 was in 1 mM Tris-HCl pH=8.0 and 150 mM NaCl. 
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Table 6: Kinetic parameters for Zn
2+
 binding to MamM CTD WT and PS. 
 
 
 
 
 
 
 
 
 
 
 
 
 
a
 Relates to WT. 
b
 Determined from the total amplitudes.  
Left parameters relate to WT, right parameters relate to PS. 
Conditions were as follows: 10 mM Tris (pH 8.0) and 150 mM NaCl at 25 °C. 
 
 
  
Parameter  WT  PS 
    
   //      
  (sec
-1
) 39.2  1.4 29.4  1.6  
    (
 
   
   (μM) 62.6  13.0 19.4  17.2 
        
   (μM sec-1) a 0.63  0.14 - 
    
    //      
        
  (sec
-1
) 0.52  2.32 95.1  40.4 
     
  (sec
-1
) - 65.7  38.8 
    
  - 0.45  0.27 
           (sec
-1
) 2.4  0.1 4.6  0.1 
           (sec
-1
) 0.20  0.07 0.46  0.02 
   (μM) 
b
 33.9  1.3 39.5  2.2 
   
b
 1.61  0.13 2.1  0.2 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
Schema 
 
Scheme 1: 
 
 
 
Scheme 2: 
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Figure 1: MamM CTD crystal structures and models. (A) The dimeric apo MamM CTD WT 
structure (PDB ID: 3W5X). The binding site residues (D249, H264, H285, E289, light green) and the 
fluorescence-active tryptophan residue (W247, yellow) are indicated. Black arrows correspond to the 
proposed movement of the monomers toward each other. (B) The new crystal structures of C267S
 
(pink, PDB ID: 6G55), CS-C267S (purple, PDB ID: 6G5E) and CS (cyan, PDB ID: 6G64) 
overlapped onto the WT structure (yellow, PDB ID: 3W5X [13]). All mutation site residues (both in 
mutants and WT proteins) are indicated as sticks. (C) Using the PDB ID: 3W5Y [13] an MMM-
modelled structure of WT MamM CTD is presented including the computed rotamer library of MTSL 
spin labels attached to position C275 [22]. (D) The new crystal structure of W247A
 
(light blue, PDB 
ID: 6G6I) overlapped onto the WT structures (PDB ID: 3W5X in yellow and PDB ID: 3W5Y in 
orange). All mutation site residues (both in mutants and WT proteins) are indicated as sticks.  
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Figure 2: CD spectra of MamM CTD in the apo and metal-bound forms. To ensure that no metals are 
bound to MamM CTD proteins, proteins were pre-incubated with EDTA for 5 hours, which was 
subsequently removed by dialysis over-night. The proteins were diluted to a final concentration of 0.3 
mg mL
-1
, with or without Zn
2+
 (15:1 Zn
2+
 to protein ratio), and spectral profiles were measured in a 
wavelength range of 200-260 nm. Darker colors refer to the apo forms and lighter colors to the metal-
bound forms; WT in green, PS in red and CS in blue. 
 
 
 
 
 
 
Figure 3: Four-pulse PELDOR experiments of doubly spin-labelled MamM CTD constructs 
containing C275, in both apo and Zn
2+
-bound forms, measured at 60 K. (Top panel) Green, blue and 
red traces are the normalized background-corrected dipolar evolution of (A) C267S, (B) CS-C267S 
and (C) PS-C267S MamM CTD respectively. The traces for both apo and Zn
2+
-bound forms are 
presented in light and dark colors, respectively. All raw time traces were subjected to a first-order 
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polynomial background correction. Fittings of Zn
2+
-bound corrected traces are shown as black lines. 
(Bottom panel) Distance distributions of Zn
2+
-bound MamM CTD constructs (A) C267S, (B) CS-
C267S and (C) PS-C267S. Fitting of all the dipolar evolutions and subsequent distance distributions 
were calculated with DeerAnalysis2016 [23] using a Tikhonov regularisation. 
 
 
 
 
 
Figure 4: Four-pulse PELDOR titrations of doubly spin-labelled MamM CTD C267S and PS-C267S 
constructs containing C275, measured at 60 K. (A) The normalised and background-corrected dipolar 
evolution of C267S (left) and PS-C267S (right) MamM CTD following Zn
2+ 
titration, with 
metal:protein ratios ranging from 1:1 to 10:1 excess and 1:1 to 5:1 excess, respectively (coloured 
lines). All raw time traces were subjected to a first-order polynomial background correction. Spectral 
fittings are shown as black lines. (B) Distance distributions corresponding to each titre of Zn
2+
-bound 
C267S (left) and PS-C267S (right). Fitting of the dipolar evolutions and subsequent distance 
distributions were calculated with DeerAnalysis2016 [23] using a Tikhonov regularisation. 
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Figure 5: Complex dynamics as described by the two set frequencies mode 7 (the native-like open-
close movement, top panel) and mode 8 (the swiveling movement, bottom panel) of WT (green, left) 
and PS (red, right). Size and direction of motions along the modes are represented by arrows. 
 
 
Figure 6: ITC measurements of MamM CTD-Zn
2+
 interactions. (Top panel) Corrected heat rate time 
curves for a representative titration for each MamM CTD construct with Zn
2+
. For each protein (left- 
WT in green, middle- PS in red and right- CS in blue), the heat flow curve of the control (Zn
2+
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titration in buffer, gray) is given as a reference. (Bottom panel) Titration data after peak integration as 
a function of molar ratio, and data fitting for both WT and PS. See Table 5 for binding parameters of 
WT and PS. 
 
 
Figure 7: Fluorescence scans of MamM CTD constructs with varying Zn
2+
 concentrations. MamM 
CTD proteins at 5 µM concentration were titrated using a ZnCl2 solution to reach different MamM 
CTD:Zn
2+
 ratios (intensity was normalized due to the change in MamM CTD concentration) and 
emission spectra were recorded. Samples were measured at an excitation of λex 297 nm and the 
emission spectrum for each ZnCl2 concentration was recorded between 310-450 nm. For each protein, 
the data presented is the average of three independent measurements. (A) Emission spectra of WT 
with different Zn
2+
 concentrations, (B) Emission spectra of PS with different Zn
2+
 concentrations, (C) 
Emission spectra of CS with different Zn
2+
 concentrations, (D) Emission spectra of 5 µM WT, 10 µM 
D247A and buffer as a control, (E) λmax as function of MamM CTD:Zn
2+
 ratio (WT in green, PS red 
and CS in blue), (F) Normalized fluorescence intensity compared to no Zn
2+
 as function of MamM 
CTD:Zn
2+
 ratio (WT in green, PS red and CS in blue). Errors are reported as the standard deviation. 
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Figure 8: Stopped flow measurements of MamM CTD binding to Zn
2+
. (A) Representative time 
courses of WT tryptophan fluorescence enhancement after a rapid mixing of WT (2.5 µM, final 
protein concentration) with different Zn
2+
 concentrations. Datasets are averaged transients (n=2 and 
for each n, at least 3 repeats were also averaged). Datasets were fitted to Equation 4 using n=1. (B) 
Representative time courses of PS tryptophan fluorescence enhancement after a rapid mixing of WT 
(2.5 uM, final concentration) with different Zn
2+
 concentrations. Datasets are averaged transients (n=2 
and for each n, at least 3 repeats were averaged). Datasets were fitted to Equation 4 using n=1. (C) 
Representative time courses of CS tryptophan fluorescence enhancement after a rapid mixing of CS 
(2.5 µM, final concentration) with different Zn
2+
 concentrations. Datasets are averaged transients 
(using n=2 while for each n, at least 3 repeats were averaged). (D) kobs of WT (green) and PS (red) 
plotted as function of Zn
2+
 concentration. Datasets were fitted to a hyperbolic function (Equations 1 & 
3). For PS, only the 2
nd
 phase (40-230 µM Zn
2+
) could be fitted. Error bars are shown within the 
symbols. (E) Amplitude of WT and PS plotted as function of Zn
2+
 concentration. Datasets were fitted 
to the Hill equation (Equation 2) for WT and PS’s first phase (15-110 µM Zn2+). Error bars are shown 
within the symbols. (F)+(G) Zn
2+
 dissociation experiments for MamM CTD: Representative time 
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courses of tryptophan fluorescence enhancement after a rapid mixing of: (F) dark green – 2.5 µM WT 
with buffer, light green – 2.5 µM WT + 150 µM Zn2+ with 2.5 mM EDTA, (G) red – 2.5 µM PS with 
buffer, magenta – 2.5 µM PS + 150 µM Zn2+ with 2.5 mM EDTA (final concentrations). Datasets are 
averaged transients (with n=1, at least 4 repeats were averaged). Datasets were fitted using Equation 4 
with n=2. Insets: the same data presented on a logarithmic scale.  
 
 
 
Figure 9: A binding mechanism model for WT and PS. Top row, green- A three step binding 
mechanism for WT as described in Scheme 1: first a rapid step in which one Zn
2+
 binds to the central 
site, followed by fast Zn
2+
 binding to the peripheral sites and a slower isomerization step to achieve 
the final, three-ion bound closed state. Bottom row, red- A two-step binding mechanism for PS as 
described in Scheme 2: a slow step in which an isomerization between different apo swiveling forms 
occurs, followed by fast Zn
2+
 binding to the peripheral sites that is only allowed by one apo form, and 
packing of the dimer to a similar, but yet tighter conformation than that of the WT. Lower left box; 
An overlapped representation of the WT
O
 and PS
SC 
forms to demonstrate the difference between the 
swiveling movement and the standard CTD’s closure movement.  
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Figure 10: CDF protein CTDs conserved binding sites. (A) The dimeric CTD crystal structures of 
Zn
2+
-bound MamB (light orange, PDB ID: 5HO1[14]), Zn
2+
-bound CzrB (pink, PDB ID: 3BYR[12]), 
Zn
2+
-bound E. coli YiiP (blue, PDB ID: 3H90[9]) and Zn
2+
-bound S. oneidensis YiiP (purple, PDB 
ID: 5VRF[10]) overlapped onto the dimeric apo MamM CTD WT structure (yellow, PDB ID: 
3W5X[13]). For all the bound structures, the Zn
2+
 ions are indicated in the structure color. (B) The 
dimeric crystal structures of Zn
2+
-bound MamB CTD (light orange) and apo MamB CTD (dark 
orange, PDB ID: 5HO5[14]) overlapped onto the dimeric apo MamM CTD WT structure (yellow). 
MamB’s Zn2+ ions, the Zn2+ ions chelating water molecules, MamB’s central binding site residues and 
their homologous residues from MamM are indicated as sticks. (C) Magnification of the monomeric 
central binding site of MamB and MamM. The residues are labeled so that the upper labels in italics 
refer to MamM’s residues and the lower labels to MamB’s residues. The D249 and H285 residues in 
MamM CTD central binding site are conserved in MamB, where they were shown to participate 
directly in the chelation of the metal ion. (D) The dimeric CTD crystal structures of Zn
2+
-bound CzrB 
(pink), Zn
2+
-bound E. coli YiiP (blue) and Zn
2+
-bound S. oneidensis YiiP (purple) overlapped onto the 
dimeric apo MamM CTD WT structure (yellow). All proteins’ bound Zn2+ ions, all the Zn2+ ions 
binding site residues and their homologous residues from MamM are indicated as sticks. (E) 
Magnifications of the peripheral binding site of CzrB, YiiP proteins and MamM (only this site is 
shown for clarity). The residues are labeled so that the upper labels in italics refer to MamM’s 
residues and the lower labels to CzrB’s residues. The H264 (left panel) and E289 (right panel) 
residues in MamM CTD peripheral binding site are conserved in YiiP and CzrB proteins, where they 
were shown to participate directly in the chelation of the Zn
2+
 ion. 
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Supporting Information 
 
Appendix S1: Derivation of Equation 3 for the PS kinetic model.  
 
 
 
 
 
 
  
